# Guaifenesin and Pseudoephedrine HCl

NDC: 62207-827
Generic name: Guaifenesin and Pseudoephedrine HCl
Labeler / Manufacturer: Granules India Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20230601

FDA application: ANDA216082

## Active ingredients

- GUAIFENESIN: 600 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62207-827"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62207-827
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75f4ff44-02e7-4a23-a394-85fe8b442e1a